Varicella vaccination in Japan, South Korea, and Europe

Catherine Sadzot-Delvaux; Bernard Rentier; Peter Wutzler; Yoshizo Asano; Sadao Suga; Tetsushi Yoshikawa; Stanley A. Plotkin

doi:10.1086/522163

Varicella vaccination in Japan, South Korea, and Europe

Catherine Sadzot-Delvaux, Bernard Rentier, Peter Wutzler, Yoshizo Asano, Sadao Suga, Tetsushi Yoshikawa, Stanley A. Plotkin

小児科学

研究成果: Article › 査読

51 被引用数 (Scopus)

抄録

The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.

本文言語	English
ページ（範囲）	S185-S190
ジャーナル	Journal of Infectious Diseases
巻	197
号	SUPPL. 2
DOI	https://doi.org/10.1086/522163
出版ステータス	Published - 01-03-2008

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Infectious Diseases

文献へのアクセス

10.1086/522163

フィンガープリント「Varicella vaccination in Japan, South Korea, and Europe」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

@article{de026ed1457d4ff88f6426fce006e9f5,

title = "Varicella vaccination in Japan, South Korea, and Europe",

abstract = "The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.",

author = "Catherine Sadzot-Delvaux and Bernard Rentier and Peter Wutzler and Yoshizo Asano and Sadao Suga and Tetsushi Yoshikawa and Plotkin, {Stanley A.}",

note = "Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Varicella Vaccine in the United States: A Decade of Prevention and the Way Forward,” sponsored by the Research Foundation for Microbial Diseases of Osaka University, GlaxoSmithKline Biologicals, the Sabin Vaccine Institute, the Centers for Disease Control and Prevention, and the March of Dimes.",

year = "2008",

month = mar,

day = "1",

doi = "10.1086/522163",

language = "English",

volume = "197",

pages = "S185--S190",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "SUPPL. 2",

}

TY - JOUR

T1 - Varicella vaccination in Japan, South Korea, and Europe

AU - Sadzot-Delvaux, Catherine

AU - Rentier, Bernard

AU - Wutzler, Peter

AU - Asano, Yoshizo

AU - Suga, Sadao

AU - Yoshikawa, Tetsushi

AU - Plotkin, Stanley A.

N1 - Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Varicella Vaccine in the United States: A Decade of Prevention and the Way Forward,” sponsored by the Research Foundation for Microbial Diseases of Osaka University, GlaxoSmithKline Biologicals, the Sabin Vaccine Institute, the Centers for Disease Control and Prevention, and the March of Dimes.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.

AB - The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.

UR - http://www.scopus.com/inward/record.url?scp=42549157579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549157579&partnerID=8YFLogxK

U2 - 10.1086/522163

DO - 10.1086/522163

M3 - Article

C2 - 18419395

AN - SCOPUS:42549157579

VL - 197

SP - S185-S190

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - SUPPL. 2

ER -